Skip to main content
pCPA File Number:
21690
Negotiation Status:
Concluded with an LOI
Indication(s):
Migraine, prevention
Sponsor/Manufacturer:
Eli Lilly Canada Inc.
CDA-AMC Project Number:
SR0693-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: